Skip to main content
. Author manuscript; available in PMC: 2020 Dec 22.
Published in final edited form as: Mol Pharm. 2015 Oct 2;12(11):3986–3998. doi: 10.1021/acs.molpharmaceut.5b00432

Table 1.

Affinity of ADCs 3–6 for Their Purified Antigens, ErbB2 and CD98, Determined via SPR

antibody or ADC antigen ka (M−1
s−1)
kd (s−1) KD
(nM)
trastuzumab ErbB2 6.1 × 105 1.4 × 10−4 0.23
5 (TRA–DBM-MMAF) ErbB2 5.9 × 105 1.4 × 10−4 0.24
3 (TRA–MC-MMAF) ErbB2 5.7 × 105 1.4 × 10−4 0.25
IGNX CD98 1.6 × 105 2.1 × 10−4 0.14
6 (IGNX–DBM-MMAF) CD98 1.4 × 105 2.6 × 10−4 0.18
4 (IGNX–MC-MMAF) CD98 1.5 × 105 2.4 × 10−4 0.16